Literature DB >> 24350075

Correlation of severity of coronary artery disease with insulin resistance.

Mukund P Srinivasan1, Padmanabh K Kamath2, Poornima A Manjrekar3, B Unnikrishnan4, Aishwarya Ullal5, Mohammed Faheem Kotekar5, Chakrapani Mahabala1.   

Abstract

BACKGROUND: Insulin resistance (IR) has known to be associated with coronary artery disease (CAD), but the assessment of severity of the CAD based on IR in type 2 diabetes mellitus has not been established in detail. AIMS: The aim of our study was to establish the correlation between IR and the severity of CAD in type 2 diabetes mellitus.
MATERIALS AND METHODS: In a cross-sectional study design, 61 consecutive patients with type 2 diabetes mellitus who underwent coronary angiogram for the evaluation of CAD were recruited. Fasting blood glucose, fasting insulin levels, systolic blood pressure and total cholesterol/high density lipoprotein-cholesterol ratio were determined. Homeostasis model assessment-IR (HOMA-IR) was correlated with severity of CAD, which was measured by modified Gensini Score.
RESULTS: There was a significant correlation between log HOMA-IR and severity of CAD (r = 0.303, P = 0.009) in diabetic patients. Correlation of the Gensini Score with other known risk factors was not significant.
CONCLUSIONS: The results of our study indicate that we might able to predict the severity of CAD by measure of IR.

Entities:  

Keywords:  Coronary artery disease; Insulin resistance; Type 2 diabetes mellitus

Year:  2013        PMID: 24350075      PMCID: PMC3842704          DOI: 10.4103/1947-2714.120799

Source DB:  PubMed          Journal:  N Am J Med Sci        ISSN: 1947-2714


  15 in total

Review 1.  Use and abuse of HOMA modeling.

Authors:  Tara M Wallace; Jonathan C Levy; David R Matthews
Journal:  Diabetes Care       Date:  2004-06       Impact factor: 19.112

2.  UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group.

Authors:  D R Matthews; C A Cull; I M Stratton; R R Holman; R C Turner
Journal:  Diabet Med       Date:  1998-04       Impact factor: 4.359

3.  Insulin resistance in Type 2 diabetes and obesity: implications for endothelial function.

Authors:  Amir Aziz; Stephen Wheatcroft
Journal:  Expert Rev Cardiovasc Ther       Date:  2011-04

4.  Insulin resistance as a predictor for restenosis after coronary stenting.

Authors:  Kazuaki Nishio; Tomoyasu Fukui; Fumiyoshi Tsunoda; Kitaro Kawamura; Seiji Itoh; Noburu Konno; Kou Ozawa; Takashi Katagiri
Journal:  Int J Cardiol       Date:  2004-12-19       Impact factor: 4.164

5.  Plasma insulin as coronary heart disease risk factor: relationship to other risk factors and predictive value during 9 1/2-year follow-up of the Helsinki Policemen Study population.

Authors:  K Pyörälä; E Savolainen; S Kaukola; J Haapakoski
Journal:  Acta Med Scand Suppl       Date:  1985

6.  Decreased insulin sensitivity is associated with the extent of coronary artery disease in patients with angina.

Authors:  K Kwon; D Choi; B K Koo; S K Ryu
Journal:  Diabetes Obes Metab       Date:  2005-09       Impact factor: 6.577

7.  Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations.

Authors:  T A Welborn; K Wearne
Journal:  Diabetes Care       Date:  1979 Mar-Apr       Impact factor: 19.112

8.  HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study.

Authors:  Enzo Bonora; Gianni Formentini; Francesco Calcaterra; Simonetta Lombardi; Franco Marini; Luciano Zenari; Francesca Saggiani; Maurizio Poli; Sandro Perbellini; Andrea Raffaelli; Vittorio Cacciatori; Lorenza Santi; Giovanni Targher; Riccardo Bonadonna; Michele Muggeo
Journal:  Diabetes Care       Date:  2002-07       Impact factor: 19.112

Review 9.  The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes.

Authors:  S E Kahn
Journal:  Diabetologia       Date:  2003-01-11       Impact factor: 10.122

Review 10.  Clinical application of incretin-based therapy: therapeutic potential, patient selection and clinical use.

Authors:  David M Kendall; Robert M Cuddihy; Richard M Bergenstal
Journal:  Am J Med       Date:  2009-06       Impact factor: 4.965

View more
  12 in total

Review 1.  Stabilization of high-risk plaques.

Authors:  Kohei Takata; Satoshi Imaizumi; Bo Zhang; Shin-Ichiro Miura; Keijiro Saku
Journal:  Cardiovasc Diagn Ther       Date:  2016-08

2.  Relationship of American Heart Association's Life Simple 7, Ectopic Fat, and Insulin Resistance in 5 Racial/Ethnic Groups.

Authors:  Parag Anilkumar Chevli; Anurag Mehta; Matthew Allison; Jingzhong Ding; Khurram Nasir; Michael J Blaha; Ron Blankstein; Sameera A Talegawkar; Alka M Kanaya; Michael D Shapiro; Morgana Mongraw-Chaffin
Journal:  J Clin Endocrinol Metab       Date:  2022-05-17       Impact factor: 6.134

3.  Does homeostasis model assessment of insulin resistance have a predictive value for post-coronary artery bypass grafting surgery outcomes?

Authors:  Ebuzer Aydin; Mehmet Ozkokeli
Journal:  Rev Bras Cir Cardiovasc       Date:  2014 Jul-Sep

4.  Association of insulin resistance and coronary artery remodeling: an intravascular ultrasound study.

Authors:  Sang-Hoon Kim; Jae-Youn Moon; Yeong Min Lim; Kyung Ho Kim; Woo-In Yang; Jung-Hoon Sung; Seung Min Yoo; In Jai Kim; Sang-Wook Lim; Dong-Hun Cha; Seung-Yun Cho
Journal:  Cardiovasc Diabetol       Date:  2015-06-06       Impact factor: 9.951

5.  Insulin Resistance and Atherosclerosis: Is it Time to Measure HOMA-IR to Predict Coronary Artery Disease?

Authors:  Lakshmi Kannan; Arthur Chernoff
Journal:  N Am J Med Sci       Date:  2013-10

6.  Reduced cholesterol is associated with the depressive-like behavior in rats through modulation of the brain 5-HT1A receptor.

Authors:  Shuqin Sun; Shuo Yang; Yongjun Mao; Xiujuan Jia; Zheng Zhang
Journal:  Lipids Health Dis       Date:  2015-03-24       Impact factor: 3.876

7.  HOMA-IR is associated with significant angiographic coronary artery disease in non-diabetic, non-obese individuals: a cross-sectional study.

Authors:  Márcio Mossmann; Marco V Wainstein; Sandro C Gonçalves; Rodrigo V Wainstein; Gabriela L Gravina; Marlei Sangalli; Francine Veadrigo; Roselene Matte; Rejane Reich; Fernanda G Costa; Marcello C Bertoluci
Journal:  Diabetol Metab Syndr       Date:  2015-11-14       Impact factor: 3.320

8.  Association of metabolic syndrome with severity of coronary artery disease.

Authors:  Namita Mahalle; M K Garg; Sadanand S Naik; Mohan V Kulkarni
Journal:  Indian J Endocrinol Metab       Date:  2014-09

9.  Factors associated with no apparent coronary artery disease in patients with type 2 diabetes mellitus for more than 10 years of duration: a case control study.

Authors:  Mukund P Srinivasan; Padmanabh K Kamath; Narayan M Bhat; Narasimha D Pai; Poornima A Manjrekar; Chakrapani Mahabala
Journal:  Cardiovasc Diabetol       Date:  2015-10-31       Impact factor: 9.951

10.  Assessment of Insulin Resistance in Subjects with Normal Glucose Tolerance, Hyperinsulinemia with Normal Blood Glucose Tolerance, Impaired Glucose Tolerance, and Newly Diagnosed Type 2 Diabetes (Prediabetes Insulin Resistance Research).

Authors:  Guang Yang; Chunlin Li; Yanping Gong; Fusheng Fang; Hui Tian; Jian Li; Xiaoling Cheng
Journal:  J Diabetes Res       Date:  2015-12-07       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.